Skip to main content

Pharmacy

By Jeff Lagasse | 02:03 pm | April 29, 2021
The organization also raised its 2021 manufacturing supply forecast to between 800 million to 1 billion doses.
By Susan Morse | 12:04 am | April 29, 2021
Biden wants to keep the lower ACA premiums available under the American Rescue Plan.
By Susan Morse | 06:18 pm | April 23, 2021
Some members expressed concern that women would not be adequately informed of the risks posed by J&J vaccination.
By Susan Morse | 11:27 am | April 23, 2021
The committee meets from 11 a.m. to 5 p.m. today in a meeting open to the public.
By Susan Morse | 10:00 am | April 22, 2021
The U.S. is reaching a tipping point where supply of the vaccine may soon outstrip demand.
By Healthcare Finance Staff | 03:20 pm | April 20, 2021
This is our continuing coverage of the steps being taken to get every American inoculated against the coronavirus.
By Jeff Lagasse | 04:34 pm | April 19, 2021
The J&J scientists said that out of 75,000 participants in a clinical trial, there was just one case of cerebral venous sinus thrombosis.
By Jeff Lagasse | 01:50 pm | April 19, 2021
While none are officially FDA approved, the agency has cleared them under emergency use authorization.
By Susan Morse | 11:51 am | April 15, 2021
Even with temporary hold on third vaccine, there is enough of a supply of Moderna and Pfizer to vaccinate every American, Biden says.
By Jeff Lagasse | 04:01 pm | April 14, 2021
Vaccine opposition at a social media event inspired the creation of new guidelines to combat misinformation.